COVID-19 mRNA booster provides additional protection, most beneficial for older adults

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.
“There is a need for a better understanding of the effect of age and the timing between booster doses on the vaccine’s efficacy and durability to help inform vaccination recommendations,” Dean Follmann, PhD, chief of the biostatistics research branch at the National Institute of Allergy and Infectious Diseases, told Healio.
“This

BOSTON — Boosting with mRNA-1273 provided additional COVID-19 protection during the delta and omicron waves, and especially among older adults, according to data from the phase 3 coronavirus efficacy (COVE) trial presented at IDWeek.
“There is a need for a better understanding of the effect of age and the timing between booster doses on the vaccine’s efficacy and durability to help inform vaccination recommendations,” Dean Follmann, PhD, chief of the biostatistics research branch at the National Institute of Allergy and Infectious Diseases, told Healio.
“This